Two different anti-erythroid monoclonal antibodies in immunodiagnosis of human leukemias: a comparative study. 1989

N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
Cancer Research Center, Moscow, USSR.

To date, only anti-glycophorin-A monoclonal antibodies (MAbs) have been widely used as anti-erythroid probes in the diagnosis of leukemias. We have examined blood, bone-marrow and lymph-node samples from 474 patients, adults and children, with different hemopoietic malignancies, using a panel of MAbs including 2 anti-erythroid MAbs directed to glycophorin-A and an antigen of erythroblasts, Ag-Eb. MAb HAE9 directed against a human epitope of Ag-Eb has earlier been shown to be highly specific for immature erythroid cells. Of all the patients, 2.7% demonstrated glycophorin-A expression on blast cells, while anti-Ag-Eb MAb HAE9 reacted positively with cells from 6.0% of patients. Samples from 31 of 474 (6.5%) patients expressed one or both erythroid markers. Our results indicate that MAb HAE9 may be useful, in combination with anti-glycophorin-A MAbs, as an anti-erythroid probe for immunophenotyping human leukemias.

UI MeSH Term Description Entries
D007159 Immunologic Tests Immunologic techniques involved in diagnosis. Diagnosis, Immunological,Immunodiagnosis,Diagnosis, Immunologic,Immunologic Diagnosis,Immunologic Test,Immunological Tests,Tests, Immunologic,Diagnoses, Immunologic,Diagnoses, Immunological,Immunodiagnoses,Immunologic Diagnoses,Immunological Diagnoses,Immunological Diagnosis,Immunological Test,Test, Immunologic,Test, Immunological,Tests, Immunological
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
January 1986, Eksperimental'naia onkologiia,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
January 1987, Parasitology today (Personal ed.),
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
June 1999, Klinicheskaia laboratornaia diagnostika,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
February 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
December 1981, Immunology letters,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
October 1987, European journal of immunology,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
January 1984, International journal of nuclear medicine and biology,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
January 1979, Medicina,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
January 1993, Human antibodies and hybridomas,
N N Tupitsyn, and E B Mechetner, and Baryschnikov AJu, and T S Drozdova, and M A Frenkel, and E S Ievleva, and A V Kiselev, and A A Perilov, and I S Peterson, and N A Probatova
December 1985, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
Copied contents to your clipboard!